Followers | 35 |
Posts | 6308 |
Boards Moderated | 0 |
Alias Born | 02/09/2015 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, August 23, 2015 8:09:27 PM
So what is new re K? Before the recent attack, in April, CEO already said stuff NOT said at ASCO, that "some" tumors stabilized and that p21 increases were dose dependent. Truly new?
1- more specific info about stabilization on CT scans of ovarian CA pts at 3 and 6 months
2-one thymoma pt has been stable for 11 months
3-additional info about p21 and gyn malignancies
4-2/2 prostate ca pts increased p21
what we wanna know:
later cohort responses
new dosing regimens
publish the dose response data when you can
CEO says phase 1 near to a close.
For you Harry Potter fans who recall the phrase open at the close: I predict: as Phase 1 closes the very wide and spectacular possibilities of kevetrin will open:
K + cytarabine + sunitinb + cisplat + immunotherapy + radiation for all those cancers out there..
That is the future that I think we will see.
Will it come true? No one knows right now but all eyes are on the next bits of info. How much more will we know as phase 1 ends, vs next phases with more specific treatments and combo therapies?
I sense this is the real deal and have invested accordingly. K could also flop- that is still entirely possible. Leo cherrypicks early data that will tell a false tale in the end? Or, early data promising, the story unfolds?
That is the real drama here, as we all know, not the short term ups and downs.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
FEATURED ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM